Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.36 (
caspase-1
)
6,285
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is widely accepted that inflammasomes protect the host from microbial pathogens by inducing inflammatory responses through
caspase-1
activation. Here, we show that the inflammasome components ASC and NLRP3 are required for resistance to pneumococcal pneumonia, whereas
caspase-1
and caspase-11 are dispensable. In the lung of S. pneumoniae-infected mice, ASC and NLRP3, but not
caspase-1
/11, were required for optimal expression of several mucosal innate immune proteins. Among them, TFF2 and
intelectin
-1 appeared to be protective against pneumococcal pneumonia. During infection, ASC and NLRP3 maintained the expression of the transcription factor SPDEF, which can facilitate the expression of the mucosal defense factor genes. Moreover, activation of STAT6, a key regulator of Spdef expression, depended on ASC and NLRP3. Overexpression of these inflammasome proteins sustained STAT6 phosphorylation induced by type 2 cytokines. Collectively, this study suggests that ASC and NLRP3 promote airway mucosal innate immunity by an inflammasome-independent mechanism involving the STAT6-SPDEF pathway.
...
PMID:ASC and NLRP3 maintain innate immune homeostasis in the airway through an inflammasome-independent mechanism. 3127 75